Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
United Therapeutics: Critical September IPF Data Catalyst Sets Up Momentous Year
09:53am, Wednesday, 27'th Aug 2025
United Therapeutics Corporation remains a Buy as it robustly defends its PAH franchise, counters competitive threats, and posts strong Q2 results with double-digit growth. Upcoming TETON-2 data for Ty
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
07:00am, Friday, 01'st Aug 2025
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced that it will enter today into two Accelerate
UTHR Q2 Earnings Miss Estimates, Higher Tyvaso Sales Aid Revenues Y/Y
11:16am, Thursday, 31'st Jul 2025
United Therapeutics' second-quarter earnings miss estimates, while revenues rise 12% on strong Tyvaso and other product sales.
Earnings Summary on United Therapeutics
01:23am, Thursday, 31'st Jul 2025
Earnings Summary on United Therapeutics
United Therapeutics Corporation (UTHR) Q2 2025 Earnings Call Transcript
10:51pm, Wednesday, 30'th Jul 2025
United Therapeutics Corporation (NASDAQ:UTHR ) Q2 2025 Earnings Conference Call July 30, 2025 9:00 AM ET Company Participants C.Q. Deng - Corporate Participant Dewey Steadman - Head of Investor Relati
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock
10:45am, Wednesday, 30'th Jul 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Compared to Estimates, United Therapeutics (UTHR) Q2 Earnings: A Look at Key Metrics
10:31am, Wednesday, 30'th Jul 2025
Although the revenue and EPS for United Therapeutics (UTHR) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with W
United Therapeutics (UTHR) Misses Q2 Earnings Estimates
08:35am, Wednesday, 30'th Jul 2025
United Therapeutics (UTHR) came out with quarterly earnings of $6.41 per share, missing the Zacks Consensus Estimate of $6.8 per share. This compares to earnings of $5.85 per share a year ago.
United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results
06:30am, Wednesday, 30'th Jul 2025
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced record financial results for the quart
United Therapeutics (UTHR) Crossed Above the 50-Day Moving Average: What That Means for Investors
10:50am, Thursday, 24'th Jul 2025
From a technical perspective, United Therapeutics (UTHR) is looking like an interesting pick, as it just reached a key level of support. UTHR recently overtook the 50-day moving average, and this sugg
United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?
11:06am, Wednesday, 23'rd Jul 2025
United Therapeutics (UTHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:50am, Wednesday, 23'rd Jul 2025
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Here's Why United Therapeutics (UTHR) is a Strong Value Stock
10:40am, Friday, 18'th Jul 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025
07:00am, Wednesday, 16'th Jul 2025
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its second quarter 2025 financial results before
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term
10:46am, Friday, 11'th Jul 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
